Introduction {#Sec1}
============

PBX1 is a TALE (three amino acid loop extension) family non-HOX homeodomain transcription factor involved in the execution of multiple developmental programs of gene expression. PBX1 cooperatively binds DNA together with HOX proteins from paralogue groups 1--10 as well as several transcription factors, e.g., Engrailed, Pdx1, and Prep/Meis (Chang et al. [@CR8]; Lu and Kamps [@CR36]; Peltenburg and Murre [@CR40]; Shen et al. [@CR57], [@CR58]; Knoepfler et al. [@CR24]; Berthelsen et al. [@CR6]; Goudet et al. [@CR17]). Cooperative interactions of PBX1 and its partner proteins modify HOX protein DNA binding (Mann and Chan [@CR37]). The functional importance of these interactions has been revealed by the observation that the PBX1 nullizygous embryos exhibit diffuse patterning defects restricted to the domains specified by Hox paralogues that bear the PBX dimerization motif (Selleri et al. [@CR56]). On the side of PBX, interactions with HOX partners are facilitated by residues within the homeodomain and immediate carboxy-terminal to it (Chang et al. [@CR9]; Lu and Kamps [@CR36]; Piper et al. [@CR42]). PBX--HOX complexes are thought either to positively or negatively regulate expression of target genes dependent on the context of cell signaling (Saleh et al. [@CR49]). In particular, activation of the protein kinase A pathway has been shown to switch PBX--HOX complexes from repressors to activators of transcription (Saleh et al. [@CR48]). Loss of PBX1 is associated with decreased cellular proliferation during development of bone, pancreas, blood, kidney, and the male genital ridge (DiMartino et al. [@CR12]; Selleri et al. [@CR56]; Kim et al. [@CR23]; Schnabel et al. [@CR53], [@CR54]). However, it is not clear how PBX1 regulates early embryonic lineage commitment. To address this issue, we generated mouse embryonic stem cells bearing a homozygous deletion of exon-6 of the *pbx1* gene, coding for the part of protein, which interacts with DNA and HOX proteins. Subsequently, both the wild-type (WT) and PBX1 mutant cells were differentiated in vitro using retinoic acid (RA) induction/aggregation methods, and gene expression profiles of their differentiated progeny were compared.

Materials and Methods {#Sec2}
=====================

*Vector design.* The PBX1^flox1^ targeting vector was constructed by cloning of three adjacent PBX1 genomic fragments into pflox plasmid (Chui et al. [@CR10]; Fig. [1](#Fig1){ref-type="fig"}*a*). The targeted sequence (subsequently referred to as the target) was composed of PBX1 exon-6 (1,192--1,356 bp in PBX1a AF020196 mRNA) flanked by 700 bp upstream and 280 bp downstream intronic sequences (Fig. [1](#Fig1){ref-type="fig"}*a*). Figure 1.Schematic representation of the PBX1 locus modifications. (*a*) Schematic representation of the first allele targeting by homologous recombination and subsequent transient Cre recombinase expression. The targeting vector was based on the pFlox plasmid coding loxP flanked *PGKNeo*/*HSV-TK* selection cassette. The first targeting vector contained a 1191-nucleotide fragment of PBX1 locus bearing exon-6 flanked by loxP sequences. The *Hin*dIII site within the 5′ homology arm was removed from the targeting vector to allow homologous recombination detection by Southern blot. The 5′ external probe used for the Southern blot analysis is shown as a *solid black box* above the mutated allele. *H Hin*dIII, *N Not*I, *Bg Bgl*II, *B Bam*HI, *E Eco*RI, *S Sal*I. As a result of the first homologous recombination and subsequent transient Cre expression, the sequence containing exon-6 as well as the selection cassette was removed from the first allele, yielding neomycin-sensitive ΔPBX1^+/−^ ES cell clones. (*b*) For the second targeting, the vector was modified by removing the target sequence containing exon-6 with *Bam*HI. The second round of homologous recombination yielded neomycin-resistant ΔPBX1^−/−^ clones.

*Homologous recombination detection strategy.* In the course of PBX1^flox1^ vector preparation, a *Hin*dIII restriction digest site was removed from the genomic sequence upstream of the targeted exon-6 (Fig. [1](#Fig1){ref-type="fig"}*a*). Removal of this restriction site by enzymatic digest and Klenow polymerase fill-in reaction allowed for Southern detection of homologous recombination events with the external Southern probe located upstream of the vector sequences (Fig. [1](#Fig1){ref-type="fig"}*a*,*c*).

*Targeting of the first allele.* The *Not*I linearized PBX1^flox1^ plasmid was electroporated into the E14 embryonic stem (ES) cells followed by 6 d of G418 selection. The homologous recombination positive clones were identified using external Southern probe and two polymerase chain reaction (PCR) systems (Fig. [2](#MOESM3){ref-type="supplementary-material"}; *see* online [Electronic Supplementary Material](#N0x1e10590N0x2d89d78){ref-type="supplementary-material"} for primer sequences). Figure 2.Detection of targeted genetic modification of the PBX1 locus. (*a*) Southern blot analysis of PBX1 clones after the first homologous recombination, before Cre treatment. DNAs of individual clones resistant to G418 were digested with *Hin*dIII and analyzed by Southern hybridization using a PCR-derived 5′ external southern probe (for primer sequences, *see*[Electronic Supplementary Material](#N0x1e10590N0x2d89d78){ref-type="supplementary-material"}). Shifts of WT 8-kb bands to 16-kb properly targeted allele bands were detected. (*b*) Confirmation of Southern blot analysis by long-range −8-kb PCR and standard −2-kb PCR on the 5′ and 3′ homology arms of the vector. In both PCRs, one primer was based on the sequences external to the targeting vector and one inside the vector sequence. (*c*) Southern blot analysis of the clones after Cre recombination using a 5′ external hybridization probe. Cre recombinase catalyzed removal of the selection cassette together with the target sequence resulted in a decrease of the original 16-kb band of the correctly targeted first allele to 11 kb ΔPBX1^+/−^ band (Fig. [1](#Fig1){ref-type="fig"}*c*). The second homologous recombination resulted in a shift of the 8-kb WT allele band to the 14.5-kb correctly targeted second allele band.

**CRE recombination.** Cells were electroporated with 20 μg of CMV-Cre plasmid (a kind gift of Dr. Florian Otto) and serially diluted before plating. Colonies were picked and PCR-analyzed for the loss of target and selection cassette sequences (data not shown).

**Targeting of the second allele.** A single ES cell clone carrying a desired deletion of target and selection cassette sequence in the first copy of the gene (further referred to as ΔPBX1^+/−^) was subjected to the second allele targeting with a modified PBX1^flox2^ vector (Fig. [1](#Fig1){ref-type="fig"}*b*). In PBX1^flox2^ plasmid, target sequence was removed from between loxP sequences by *Bam*HI digest and re-ligation (Fig. [1](#Fig1){ref-type="fig"}*b*). Due to this modification, integration of PBX1^flox2^ into the second copy of the PBX1 gene causes direct exon-6 ablation without the necessity of a subsequent round of CRE recombination (Fig. [1](#Fig1){ref-type="fig"}*b*).

**ES cell culture.** E14 ES cells were cultured in the presence of 1,000 U/ml of recombinant leukemia inhibitory factor (LIF; ESGRO, Chemicon International, Schwalbach, Germany) on the mitomycin (Sigma-Aldrich, Munich, Germany) treated CD-1.MTKneo2 embryonic fibroblasts according to standard procedures (Wasserman et al. [@CR65]).

**In vitro differentiation.** The cells were differentiated according to the previously described aggregation/RA induction protocol (Bain et al. [@CR4]; Gajovic et al. [@CR15]) with two modifications: Cell culture dishes were coated with 0.1% gelatin (Sigma)/20 μg/ml laminin (Gibco/Invitrogen, Karlsruhe, Germany) prior to embryoid body (EB) reattachment.The cells were allowed to differentiate for nine instead of 6 d after EB reattachment, in which time, media was exchanged daily.

**Northern blot and real-time PCR.** Total RNA was isolated from trypsinized cells using TriPure Isolation Reagent (Boehringer Mannheim, Mannheim, Germany). Reverse transcription was performed with TaqMan reverse transcription reagents (Applied Biosystems, Foster City, CA) and random hexamer primers according to supplied protocol. The reactions were done in 30-μl volumes using SYBR Green PCR master mix (Applied Biosystems) in the ABIPrism 7900HT cycler using primers listed in Fig. [3](#MOESM5){ref-type="supplementary-material"}, Electronic Supplementary Material. Results were standardized to the level of GAPDH expression using a standard curve method according to Applied Biosystems guidelines. Northern blots were carried out as described previously (Uchida et al. [@CR63]). The reverse transcriptase PCR (RT-PCR) derived probes specific for insulin growth factor-2 (IGF-2), insulin growth factor-2 receptor (IGF-2R), insulin growth factor-1 (IGF-1), insulin growth factor-1 receptor (IGF-2R), H19, Oct3/4, colipase and actin were labeled with \[-^32^P\]dCTP (3,000 Ci/mmol; Amersham Biosciences, Freiburg, Germany) using a Megaprime DNA labeling system (Amersham Biosciences).

**Western blot.** Whole cell lysates of differentiated cells were resolved by electrophoresis in 12% sodium dodecyl sulfate--polyacrylamide gels and transferred onto polyvinylidene fluoride (Amersham) as described previously (Stock et al. [@CR60]). PBX proteins were detected with PBX1/2/3 sc-888 antibody (Santa Cruz, Heidelberg, Germany) and actin with sc-1615 antibody (Santa Cruz).

**Immunostaining.** Immunostaining of β-III-tubulin and ERK1 was performed as described previously using antibodies against beta-tubulin (βIII) MMS-435P (BabCo, Berkeley, CA) and ERK1 sc-94 (Santa Cruz; Bain et al. [@CR4]).

**Gene expression profiling using oligonucleotide microarray.** Total RNA purified with the TriPure isolation reagent (Boehringer Mannheim) was repurified with RNeasy mini kit (Qiagen, Valencia, CA) and was used for experiments with Murine Genome U74A version 2 GeneChip arrays (Affymetrix, Santa Clara, CA), which contain probes for detecting 6,000 well-characterized genes and 6,000 expressed sequence tags. All labeling and hybridization steps were carried out according to Affymetrix protocols.

**Data analysis using Affymetrix software.** Scanned microarray images were analyzed with the Affymetrix microarray suite 4.0 software. The software identified differentially expressed transcripts by comparison of the differences in values of perfect match to mismatch of each probe pair in the baseline array (differentiated WT ES cells) to its matching probe pair on the experimental array (differentiated ΔPBX1^−/−^ cells). The signal log ratios calculated for each transcript were converted into fold change using Affymetrix recommended formula. The results of comparison of the WT and two PBX1 mutant clones were cross-compared, and 117 transcripts were consistently deregulated in both mutant clones selected (*see*[Electronic Supplementary Material](#N0x1e10590N0x2d89d78){ref-type="supplementary-material"}).

Results {#Sec3}
=======

**First allele targeting.** The linearized PBX1^flox1^ construct (Fig. [1](#Fig1){ref-type="fig"}*a*) was electroporated into a 129/Ola background E14 ES cell line and cultured on the embryonic fibroblast feeder layers, in the presence of LIF, according to standard protocol (Wasserman et al. [@CR65]). This strategy was chosen to create both ES cells for differentiation and generate transgenic knockout mice with the same approach. Following positive selection in G418, homologous recombinant clones were identified by Southern blot analysis using *Hin*dIII digest and the 5′ external Southern blot probe (Fig. [2](#Fig2){ref-type="fig"}*a*). This probe hybridizes to the 8-kb fragment of the wild-type allele and the 16-kb fragment of a correctly targeted allele (Fig. [2](#Fig2){ref-type="fig"}*a*). The homologous recombination events, detected by Southern blot, were confirmed by PCR amplification of the 5′ and 3′ ends of the targeting vector, with one primer based on the sequence inside and one external to the vector sequence (Fig. [2](#Fig2){ref-type="fig"}*b*).

**CRE recombination.** Two homologous recombination positive clones were expanded and electroporated with 20 μg of CMV-Cre expression vector (kind gift of Dr. Florian Otto). In the next step, two recombinant clones with the excised selection cassette and exon-6 sequences were selected in a PCR-based screen from each of the ES cell sub-lines (data not shown).

**Second allele targeting.** A single clone of Cre-treated cells, from which both the target sequence containing exon-6 and flanking intronic regions (700 bp upstream and 280 bp downstream from exon-6) of PBX1 and the selection cassette had been removed, was subjected to a second gene copy targeting procedure (Fig. [1](#Fig1){ref-type="fig"}*b*). The targeted sequence was removed from the PBX1^flox1^ vector through *Bam*HI digest and re-ligation. This PBX1^flox2^ plasmid allowed for direct inactivation of the second copy of the PBX1 gene (Fig. [1](#Fig1){ref-type="fig"}*b*). Recombinants were selected in G418 and screened using the same 5′ external Southern probe as in the first allele targeting. A shift of the 8 kb WT band to the properly targeted, 14.5 kb, second allele band was detected (Fig. [2](#Fig2){ref-type="fig"}*c*). The effect of targeting both alleles was assessed at the mRNA and protein expression level in the differentiated ΔPBX1^−/−^ cells (see following subsection).

**In vitro ES cells differentiation.** The ΔPBX1^−/−^ cells, cultured on mitomycin-C-pretreated embryonic fibroblasts in the standard medium supplemented with LIF, retained morphological features of undifferentiated ES cells. Furthermore, all analyzed sub-lines expressed the Oct3/4 gene, indicating their undifferentiated state (Fig. [6](#Fig6){ref-type="fig"}). Aggregation in the media supplemented with 1% fetal calf serum and RA was employed in order to induce neuro-ectodermal differentiation, as described in "[Materials and Methods](#Sec2){ref-type="sec"}". WT and ΔPBX1^−/−^ cells cultured in the non-adhesive bacterial grade dishes formed embryoid bodies (Fig. [3](#Fig3){ref-type="fig"}*e*--*f*), which, stimulated by RA, differentiated into morphologically distinguishable cell types (Fig. [3](#Fig3){ref-type="fig"}*g*--*h*). Wild-type cells grew densely and acquired predominantly bead-like forms structured into grainy nests (Fig. [3](#Fig3){ref-type="fig"}*g*). On the contrary, most of the differentiated ΔPBX1^+/−^ and ΔPBX1^−/−^ cells had a flat morphology, resembling mesenchymal cells (Fig. [3](#Fig3){ref-type="fig"}*h*). Figure 3.Morphology of the wild-type E14, mutant ΔPBX1^+/−^, and ΔPBX1^−/−^ ES cells growing undifferentiated on the embryonic fibroblast and differentiating upon aggregation in the presence of RA. (*a*, *b*) Low-magnification digital images of the colonies of undifferentiated WT and ΔPBX1^−/−^ embryonic stem cells. (*c*, *d*) The same colonies photographed at higher magnification. WT and mutant cells grow in sharp-bordered colonies characteristic of undifferentiated ES cells. (*e*, *f*) Embryoid bodies formed by each of the ES cell clones as a result of aggregation in non-adhesive dishes followed by RA induction. (*g*, *h*) Morphology of differentiated ES cells 9 d after reattachment to the adhesive media. The ΔPBX1^−/−^ cells have a flattened appearance as they spread in the surroundings of the reattached aggregates.*Targeted deletion of exon-6 and flanking intronic regions results in the expression of Δ(280-370)PBX1 mutant protein.* In order to determine the effect of targeting both alleles on mRNA and protein expression, we performed RT-PCR, real-time PCR, and Western blot analysis of differentiated cells. As expected, in the RT-PCR where one of the primers was designed to recognize PBX1 exon-6 region, no product could be detected in the ΔPBX1^−/−^ cells (Fig. [1](#MOESM1){ref-type="supplementary-material"}*a*, Electronic Supplementary Material).Reactions with primers designed to amplify the coding sequence of PBX1 resulted in a single band corresponding to mutant cDNA (Fig. [1](#MOESM1){ref-type="supplementary-material"}*b*, Electronic Supplementary Material). Subsequent cloning and sequencing of the transcript revealed lack of the sequences encoded by exon-6 and exon-7. Observed exon-7 skipping and loss of alternative splicing of exon-8 resulted from deletion of intronic splicing regulatory sequences (Fig. [2](#MOESM3){ref-type="supplementary-material"}, Electronic Supplementary Material).Since the lack of the exon-6 and exon-7 sequences does not result in a frame shift, the mutant cDNA encodes a protein lacking amino acids 280--370, termed here Δ(280--370)PBX1 (for the cDNA evidence, *see* Fig. [2](#MOESM3){ref-type="supplementary-material"} of Electronic Supplementary Material). The C-terminal 70 AA remains in the ΔPPBX1 translated protein. Since the antibody we used is directed against the C terminus of all three paralogues, PBX1/2/3, in Western blot, we detected expression of the Δ(280--370)PBX1 mutant protein in ΔPBX1^+/−^ and ΔPBX1^−/−^ cells (Fig. [4](#Fig4){ref-type="fig"}). Figure 4.Analysis of PBX protein and mRNA expression. (*a*) Western blot analysis of PBX1/2/3 expression in the differentiated WT, ΔPBX1^+/−^, and ΔPBX1^−/−^ cells on the ninth day after reattachment to adhesive cell culture dishes. Immunodetection of actin served as the loading control and was carried out on the same blots following PBX antibody striping. (*b*) Real-time PCR quantification of PBX2 and PBX3 transcripts in differentiated WT cells and two ΔPBX1^−/−^ clones on the ninth day after reattachment to adhesive cell culture dishes.Interestingly, Western blot revealed a large amount of full-length PBX1/2/3 protein (band above the 49-kDa marker) detected by the PBX1/2/3 antibody. In order to further explain this observation, we quantified PBX2 and PBX3 transcripts in mutant cells. Their expression was upregulated almost twofold and more than 5-fold in ΔPBX1^−/−^ cells compared with WT cells, respectively. Therefore, a high level of WT PBX protein expression in the differentiated ΔPBX1^−/−^ cells correlates with relative abundance of PBX3 transcripts (Fig. [4](#Fig4){ref-type="fig"}). See "[Discussion](#Sec4){ref-type="sec"}" for further comments on this observation.

**Comparative genome wide expression profiles of differentiated WT and ΔPBX1^*−/−*^ cell lines.** Total RNA from differentiated, RA-induced, day 9 post-attachment WT and ΔPBX1^−/−^ cell populations (one clone of wild-type cell and two clones of ΔPBX1^−/−^ cells) was hybridized to the Affymetrix Mu_U94Av2 microarray. A total of 680 genes for the first ΔPBX1^−/−^ clone and 473 genes for the second ΔPBX1^−/−^ clone were differentially expressed (two-fold or more difference) in comparison to the WT cells. Out of those, 117 commonly regulated genes were identified in both analyzed clones.A selection of the 117 gene regulations is presented in Fig. [5](#Fig5){ref-type="fig"} and the complete list is accessible at Tables [1](#MOESM7){ref-type="supplementary-material"}, [2](#MOESM8){ref-type="supplementary-material"}, and [3](#MOESM9){ref-type="supplementary-material"} of Electronic Supplementary Material (MS Excel® format available). Figure 5.The microarray-based comparative gene expression profiling of differentiated ΔPBX1^−/−^ and WT cells. Represented are regulations consistently observed in two clones of ΔPBX1^−/−^ cells. *Upper* and *lower bars* represent values of gene deregulation in ΔPBX1^−/−^ clone-1 and ΔPBX1^−/−^ clone-2, respectively, as compared to the WT cells. Fold change values are depicted *next to the bars*.

**Differentiated ΔPBX1^*−/−*^ cells exhibit intensified expression of neural and muscle specific genes.** Nine muscle (Fig. [5](#Fig5){ref-type="fig"}*b*) and ten neuron (Fig. [5](#Fig5){ref-type="fig"}*a*) specific genes were consistently upregulated in both clones of ΔPBX1^−/−^ cells. Among those, expression of striated smooth and cardiac-muscle-specific actin isoforms indicated that the ΔPBX1^−/−^ cells had acquired a muscle phenotype.Interestingly, expression of reelin, a gene known to play an important role both in brain development and neuromuscular junction formation, was upregulated in both differentiated ΔPBX1^−/−^ clones (Quattrocchi et al. [@CR44]). Expression of two EGF-related growth factors, amphiregulin (L41352) and NELL2 (U59230), reported to function as potent mitogens for the neural stem cells in vitro (Falk and Frisen [@CR13]; Aihara et al. [@CR3]) was also increased. Other neural genes, upregulated in differentiated ΔPBX1^−/−^ cells, play roles in such processes as: Cell adhesion: catenin alpha-2 (D25281; Uchida et al. [@CR63]), sialyltransferase-8 (X99646; Kojima et al. [@CR26], [@CR27]) andCytoskeleton regulation: neuronal intermediate filament protein (L27220), microtubule-associated protein tau (M18775; Lee et al. [@CR31]), mouse brain H5 (X61452; Kato [@CR21]).A slight increase of N-CAM and 3.7-fold increase of GFAP expression was observed (Table [1](#MOESM7){ref-type="supplementary-material"}, Electronic Supplementary Material).Not only the neuron-specific genes but also genes for skeletal muscle like alpha1-actin, for cardiac muscle like myosin-heavy polypeptide 7, and for smooth muscles like h2-calponin were upregulated (Table [3](#MOESM9){ref-type="supplementary-material"}, Electronic Supplementary Material)

**Decreased expression of trophectoderm and endothelial marker genes.** In addition, we detected pronounced differences in trophectodermal marker gene expression between differentiated WT and ΔPBX1^−/−^ cells. Expression of spongiotrophoblast-specific gene Tpbpa (X17071; Lescisin et al. [@CR33]), trophoblast giant-cell-specific placental lactogen-II (M85067), and proliferin (K03235; Adamson et al. [@CR1]) were downregulated (Fig. [5](#Fig5){ref-type="fig"}*c*). Similarly, genes demarcating epithelial cells derived from endoderm and mesoderm, e.g., vascular-specific endothelial-specific receptor tyrosine kinase (X71426) were downregulated (Fig. [5](#Fig5){ref-type="fig"}*c*; Sato et al. [@CR51]).Aquaporin1/CHIP28 (L02914), which is expressed predominantly in endothelium of kidney, lung, trachea, and heart, but also in placental syncytial trophoblast cells (Hasegawa et al. [@CR18]), and colipase (AA710635), expressed in pancreas, stomach, and colon (D'Agostino et al. [@CR11]), also showed decreased expression. Since colipase exhibited the strongest downregulation within this group of genes, we have further confirmed its deregulation in Northern blot, which revealed that whereas expression of colipase was strongly induced during WT ES cells differentiation, it remained silent in ΔPBX1^+/−^ and ΔPBX1^−/−^ cells (Fig. [6](#Fig6){ref-type="fig"}). Furthermore, deregulations of aquaporin1/CHIP28 (L02914) and endothelial-specific receptor tyrosine kinase (X71426) were confirmed by real-time PCR (Fig. [3](#MOESM5){ref-type="supplementary-material"}, Electronic Supplementary Material). Figure 6.Differentiated ΔPBX1^+/−^ and ΔPBX1^−/−^ cells do not express IGF2, IGF2R, and colipase genes. Total RNA (15 μg/lane) isolated from undifferentiated (*0*) and differentiated (*9*) WT, ΔPBX1^+/−^, and ΔPBX1^−/−^ embryonic stem cells was used in the Northern blot as described in "[Materials and Methods](#Sec2){ref-type="sec"}". Genotypes and stages of differentiation are assigned above the panel: (*0*) = undifferentiated, (*9*) = ninth day post-attachment of embryoid bodies to adhesive culture dishes. Efficiency of blotting was controlled by staining RNA on the membrane with ethidium bromide (*top of the panel*).

**Deregulation of imprinted genes: IGF2, IGF2R, H19, DLK-1, GTL-1, and neuronatin.** Interestingly, the microarray experiments resulted in the discovery of the striking downregulation of insulin growth factor 2 (X71922) as well as its receptor (U04710) in ΔPBX1^−/−^ cells (Fig. [5](#Fig5){ref-type="fig"}*d*).Consistently, Northern blot analysis revealed that IGF2 was expressed only in differentiated wild-type cells (Fig. [6](#Fig6){ref-type="fig"}). The IGF2 receptor was expressed in all undifferentiated cells and differentiated WT cells, whereas in differentiated ΔPBX^+/−^ and ΔPBX1^−/−^ cells, its expression was barely detectable. This IGF2 deregulation prompted us to check the expression of another imprinted gene, *H19*, known to share common regulatory sequences with IGF2 (Srivastava et al. [@CR59]). Northern blot revealed *H19* expression to be intensified in ΔPBX1^+/−^ and both ΔPBX1^−/−^ cells (Fig. [6](#Fig6){ref-type="fig"}).Similarly, H19, IGF1, and IGF1R were also slightly upregulated in the differentiated knockout cells (Fig. [6](#Fig6){ref-type="fig"}). Interestingly, three other imprinted genes, *GTL-2* (Y13832), *DLK-1* (Z12171), and *neuronatin* (X83569), were also deregulated (Fig. [5](#Fig5){ref-type="fig"}*c*). *GTL-2*, like *H19*, is expressed from the maternal allele (Schmidt et al. [@CR52]; Takada et al. [@CR62]). Its expression was induced in the differentiated ΔPBX1^−/−^ cells. The paternally expressed *DLK-1* gene encodes a homologue of the Notch-Delta family of developmental regulated signaling molecules (Laborda [@CR29]) and is co-regulated with *GTL-2*. Its expression was silenced in the ΔPBX1^−/−^ clones (Fig. [5](#Fig5){ref-type="fig"}*c*). Expression of *neuronatin* (NNAT) was induced in mutant cells. The gene is normally transcribed from the unmethylated paternal allele in neural tissue and CD34-positive blood cell progenitors (Kuerbitz et al. [@CR28]). Deregulation of imprinted genes was further confirmed by Northern blot (Fig. [6](#Fig6){ref-type="fig"}) or real-time PCR (Fig. [3](#MOESM5){ref-type="supplementary-material"}, Electronic Supplementary Material).

**Expansion of neural cell lineage in differentiating ΔPBX1^*−/−*^ ES cells.** The presence of neurons in the populations of differentiated WT and ΔPBX1^−/−^ cells was confirmed by cytoimmunochemical staining with antibody against a post-mitotic neural marker beta-III-tubulin (Tuj1; Mann and Chan [@CR37]). We observed outgrowths of neural processes in the surroundings of differentiated aggregates of both WT and PBX1 mutant cells; it was, however, most pronounced in the mutant cell cultures (Fig. [7](#Fig7){ref-type="fig"}*a*--*d*). Subsequently, the neural cell populations were quantified by fluorescence-activated cell sorting (FACS) of anti-β-III-tubulin-stained cells (Fig. [7](#Fig7){ref-type="fig"}*e*,*f*). A marked increase (\~5%) in Tuj1-positive cell numbers was detected in cultures of differentiated ΔPBX1^−/−^ cells as compared with WT cells. Figure 7.RA-treated ΔPBX1^−/−^ ES cells differentiate into neurons. (*a*, *b*) Confocal microscopy images of differentiated WT and ΔPBX1^−/−^ embryonic stem cells on the ninth day post-reattachment of embryoid bodies to adhesive media. (*c*, *d*) Expression of neuron-specific class III beta-tubulin (*red*) and extracellular signal-regulated kinases 1 (*ERK1*, *green*) were visualized by indirect immunofluorescence. A beta-III-tubilin composite of the same images. (*e*, *f*) FACS-based quantification of the beta-III-tubulin-stained, neural cell populations derived in WT (*e*) and ΔPBX1^−/−^ (*f*) cell cultures.

**Supplemental information online.** The relative fold change values of gene expression are stored in the Excel file format and can be accessed at <http://www.uniklinik-freiburg.de/medizin1/live/permalink/scheele2009.html>.

Discussion {#Sec4}
==========

**Overview of the experimental model.** Utilizing the Cre--loxP system, we targeted a functionally important part of the homeodomain of PBX1 in ES cells. Genomic modification resulted in expression of the Δ(280--370)PBX1 mutant protein (Fig. [4](#Fig4){ref-type="fig"}.). Multiple in vitro experiments and structural data have indicated that the 280--370 a.a. region facilitates both PBX1--HOX and PBX1--DNA interactions (Lu and Kamps [@CR36]; Peltenburg and Murre [@CR41]; Jabet et al. [@CR19]; Piper et al. [@CR42]; LaRonde-LeBlanc and Wolberger [@CR30]).By employing DNA microarray technology, we compared transcriptional profiles of in vitro differentiated WT and ΔPBX1^−/−^ ES cells. In the following subsections, we discuss functional aspects of the identified gene regulations.

**ΔPBX1^*−/−*^ ES cells express neural genes.** Cell aggregation and RA treatment in media with low serum content are known to lead to efficient neuroectodermal differentiation of ES cells. In the process of differentiation, various genes are expressed in a specific temporal order. Some of them are expressed by undifferentiated ES cells (OCT4, BMP4; Niwa et al. [@CR38]; Ying et al. [@CR66]) and others are upregulated during early differentiation (PAX6, Nestin, OTX1; Okabe et al. [@CR39]; Gajovic et al. [@CR15]), still others during late differentiation (β-III-tubulin, GFAP, N-CAM; Bain et al. [@CR4]; Fraichard et al. [@CR14]). Varieties of genes active in this process were revealed by a recent survey of the ES cells to neural lineage differentiation transcriptome (Ahn et al. [@CR2]).In the current study, we compared transcriptomes of WT and ΔPBX1^−/−^ mutant cells. Our results indicate that ΔPBX1^−/−^ mutant cells not only retain the capability to express neural genes in response to RA treatment but also express them at higher levels as compared with WT cells. Consistently, FACS analysis revealed relative expansion of β-III-tubulin-expressing cell population, correlating with widespread outgrowth of neural processes in cultures of differentiated PBX1 mutant cells (Fig. [7](#Fig7){ref-type="fig"}*a*--*d*). We conclude that a greater proportion of ΔPBX1^−/−^ mutant cells undergo neural differentiation as compared to WT cells. We hypothesize that the relative abundance of PBX3 transcripts in populations of differentiated ΔPBX1^−/−^ cells is a direct result of neural population expansion. Transcripts of PBX3 were recently found to be upregulated in the ES cells differentiating to midbrain and hindbrain neurons (Ahn et al. [@CR2]). Consistently, PBX3 expression in the mid-gestation mouse embryo is restricted to the central nervous system; PBX3-deficient mice have been shown to die from central respiratory failure due to abnormal activity of inspiratory neurons in the medulla (Rhee et al. [@CR46]). Furthermore, Knoepfler and Kamps ([@CR25]) have shown that retinoic acid upregulates PBX protein abundance coincident with transcriptional activation of *Hox* genes in P19 embryonal carcinoma cell undergoing neuronal differentiation. Using an approach different from double-allele knockout, other investigators applied SI-RNA technique to eliminate expression of PBX1 and the related PBX2 and PBX3 genes. They could show that PBX proteins are required for RA-induced differentiation of P19 cells (Qin et al. [@CR43]). Not only in transformed cell lines but also in the rat model did the expression of PBX1 in the subventricular zone precursor cells suggest a role of PBX1 in mammalian neurogenesis (Redmond et al. [@CR45]).

**Deregulation of myogenic, endothelial, and trophectodermal genes.** In addition, genetic markers of other cell lineages were found to be deregulated. Intensified expression of muscle-specific genes (Fig. [5](#Fig5){ref-type="fig"}*b*) accompanied that of neural markers. Based on our microarray data, we can hypothesize that mutant cells differentiate into two predominant neural and muscle cell lineages. Alternatively, expression of both neural and muscle-specific genes could be attributed to expansion of the common neuromuscular progenitor cell population.Mouse ES cells, although derived from the epiblast (Brook and Gardner [@CR7]), which, during gastrulation, does not contribute to the trophectodermal lineage (Beddington and Robertson [@CR5]), are capable of acquiring trophectodermal phenotypes upon withdrawal of LIF (Niwa et al. [@CR38]). Our results are in agreement with this observation, as the high levels of trophectodermal marker gene expression were detected in differentiated WT ES cells. However, differentiated ΔPBX1^−/−^ cells exhibited decreased expression of trophectoderm markers as well as endoderm-derived epithelial genes, suggesting involvement of PBX1 in the molecular program leading to commitment into those lineages (Fig. [5](#Fig5){ref-type="fig"}*c*).

**Deregulation of imprinted genes in ΔPBX1^*−/−*^ cells.** Interestingly, the microarray experiment resulted in the discovery of very strong downregulation of *IGF2* and *IGF2r* genes in the knockout cells. Whereas in WT cells *IGF2* and *IGF2r* expression were strongly induced during differentiation, it remained uninduced in differentiating mutant cells. Loss of expression of these genes in ΔPBX1^+/−^ and ΔPBX1^−/−^ cells could be explained either by their inability to differentiate into *IGF2*- and *IGF2r*-expressing cell populations or by loss of PBX1-mediated transcriptional regulation. A strong argument against the hypothesis of the cell population shift as a major reason for the loss of IGF2 expression is delivered by the coordinate upregulation of the *H19* gene. It has been shown that expression of these two genes in endoderm and mesoderm relies on a common set of enhancers and is almost identical spatially and temporarily (Leighton et al. [@CR32]). Interestingly, deregulation of *IGF2*, *IGF2r*, and *H19* genes in PBX1Δ280--370 mutant expressing cells resembles the situation in the DNA-methyltransferase-defficient (DNMT-1) knockout embryos where transcription of *IGF2* and its receptor is completely abolished and the normally inactive paternal copy of *H19* gene becomes activated (Li et al. [@CR34]). Additionally, two other imprinted genes, *GTL-2* and *neuronatin*, were also found to be deregulated in ΔPBX1^−/−^ cells (Takada et al. [@CR61]; Lin et al. [@CR35]). Expression of all these genes is crucially dependent on DNA methylation (Li et al. [@CR34], [@CR35]). It is therefore tempting to speculate that PBX1 has a function in establishing their methylation patterns.

Conclusions {#Sec5}
===========

In conclusion, our experimental model yielded the discovery of a variety of new genes whose expression is associated with PBX1 function. Identification of possible links between their deregulations and the phenotype of previously described PBX1 knockout mice awaits future investigation. The loss of *IGF2* expression in differentiated ΔPBX1^−/−^ cells is especially interesting in the context of decreased cellular proliferation rate in developing bone, pancreas, the hematopioetic system, kidney, and the male genital ridge of PBX1 knockout mice (DiMartino et al. [@CR12]; Schnabel et al. [@CR55], [@CR53], [@CR54]; Selleri et al. [@CR56]; Kim et al. [@CR23]). Development of most of these organs has been previously linked to the mitogenic function of *IGF2* (Van Wyk and Smith [@CR64]; Zumkeller and Burdach [@CR67]; Kido et al. [@CR22]; Kim et al. [@CR23]). In particular, the roles of PBX1 and *IGF2* are well recognized in normal pancreas development (Kido et al. [@CR22]; Kim et al. [@CR23]). Several studies have demonstrated that exocrine pancreatic development is crucially dependent upon mesenchymal/epithelial interactions, suggesting that exocrine growth factors play an essential role in this process (Jonsson et al. [@CR20]; Sanvito et al. [@CR50]; Gittes et al. [@CR16]; Rose et al. [@CR47]). Additionally, formation of acinary cell structures in vitro could be rescued in PBX1^−/−^ explants by WT mesoderm tissue in recombination experiments (Kim et al. [@CR23]). However, PBX1-regulated mesodermal growth factors, capable of rescuing exocrine pancreatic cell differentiation, were not identified.

Our data open a new possibility whereby PBX1 influences embryonic growth as well as endoderm and trophectoderm differentiation through regulation of the imprinted genes *IGF2* and *IGF2r*.

Furthermore, we establish that PBX1 interactions with HOX and DNA are dispensable for neural gene expression. The last is interesting in the light of a recent report on the permissive role of PBX proteins in RA-induced neural differentiation of *P19* carcinoma cell line (Qin et al. [@CR43]). Still, the possible involvement of the PBX1 N-terminal domain in neural commitment remains to be tested.
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###### 

(*a*) RT-PCR analysis of the PBX1 and ΔPBX1^−/−^ expression during differentiation of RA-induced and uninduced WT and ΔPBX1^−/−^ cells. RNA was isolated from three stages of differentiation of RA-induced and non-induced WT and ΔPBX1^−/−^ cells. *Lines 1--5* WT cells. *Lines 6*--*10* ΔPBX1^−/−^ (clone1). *Line 11* a negative control PCR (no template). (*0*) represents undifferentiated ES cells, (*3*) and (*9*) represent days post-attachment of embryoid bodies to adhesive culture dishes. (--) differentiation in absence of RA induction, (+) differentiation with 100 nM RA. Using 5′ region-specific primers, PBX1 transcripts were detected in both differentiating WT and mutant cells (*second panel from top*). RT-PCR reaction with one primer based on the exon-6 sequence allowed detection of the intact transcripts only in the WT and ΔPBX1^+/−^ cells. (*b*) The coding sequences of WT PBX1 and ΔPBX1^−/−^ were amplified in RT-PCR reactions with the primers: PBX1CDS-F: 5′-ATGGACGAGCAGCCGAGGC-3′; PBX1CDS-B: 5′-AAGAATCCCCATTGAGTGACTGC-3′ as described in "[Materials and Methods](#Sec2){ref-type="sec"}". The ΔPBX1^−/−^ PCR product was isolated from agarose gel with gel extraction kit (Qiagen), cloned into pCRII-TA cloning kit (Invitrogen), and sequenced (GIF 156 KB).

###### 

High resolution image file (TIF 117 KB).

###### 

Partial cDNA sequence evidence of the Δ(280--370)PBX1 mutant. The amino acid numbering is based on the WT PBX1 sequence. The region coding amino acids 280--370, absent in the mutant transcript, is highlighted in *red* (GIF 126 KB).

###### 

High resolution image file (TIF 65.8 KB).

###### 

Real-time PCR transcript quantification of selected genes found to be differentially expressed in differentiated WT and ΔPBX1^−/−^ cells. The primers used: endothelial-specific RTK-X71426: GAGGTCTCAGTCTCCTGCCAAA; TCGCCTCTCGACTTCCACATA Aquaporin1-L02914: GTTCTGCCCTAGGCTTCAATT; CAGAGTAGCGATGCTCAAACC GTL-2 Y13832: TTGCTGGCCCTGGAGATC; GGACGATGGCTAGGATTTCG Neuronatin-X83569: CCATCAACCAGCAGAATGGA; CTTTCTCTTCTGCACCGAGATGT GAPDH: GGGAAGCCCATCACCATCTT; CGGCCTCACCCCATTTG PBX2: TCCCCATTTTTGGCATCTCT; TCCCCACCCCACTTATATACTCT PBX3: CCCCGGCGCTTTCC; TTTCCTTCTCCTAGTGCTCCAAA (GIF 150 KB).

###### 

High resolution image file (TIF 61.0 KB).

###### 

Comparison of gene expression in differentiated WT and two clones of ΔPBX1^−/−^ cells using Affymetrix array analysis. Utilizing techniques described previously, RNA was isolated from ES cells at day 9 post-attachment to adhesive culture dishes. The array results for each ΔPBX1^−/−^ clone are compared to the same baseline denominator (RNA isolated from WT ES cells) and are expressed as fold change (XLS 176 KB).

###### 

Comparison of gene expression in differentiated WT and two clones of ΔPBX1^−/−^ cells using Affymetrix array analysis. Utilizing techniques described previously, RNA was isolated from ES cells at day 9 post-attachment to adhesive culture dishes. The array results for each ΔPBX1^−/−^ clone are compared to the same baseline denominator (RNA isolated from WT ES cells) and are expressed as fold change (XLS 126 KB).

###### 

Selected gene regulations from Tables 1 and 2, consistent between two clones of ΔPBX1^−/−^ cells. Genes were categorized based on subcellular localization(s) of the transcript-coded protein, cell lineage(s) demarcated by respective transcripts, as well as their function(s) (XLS 233 KB).
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